CYP19A1 binds Aromatase inhibitors
CYP19A1 + Aromatase inhibitors → CYP19A1:Aromatase inhibitors
- Reactome
- R-HSA-9707353
- Compartment
- cytosol · endoplasmic reticulum membrane
- Rhea
- None recorded
Inputs
- CYP19A1R-HSA-193137, endoplasmic reticulum membrane
- Aromatase inhibitorsR-ALL-9707314, cytosol
Outputs
- CYP19A1:Aromatase inhibitorsR-HSA-9707321, endoplasmic reticulum membrane
Literature
- Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo Steroids, 1981
- Highly selective inhibition of estrogen biosynthesis by CGS 20267, a new non-steroidal aromatase inhibitor J Steroid Biochem Mol Biol, 1990
- Approval summary: letrozole in the treatment of postmenopausal women with advanced breast cancer Clin Cancer Res, 2002
- An overview of the pharmacology and pharmacokinetics of the newer generation aromatase inhibitors anastrozole, letrozole, and exemestane Cancer, 2002
- HPMA copolymer-aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines J Drug Target, 2005
- Fadrozole hydrochloride: a potent, selective, nonsteroidal inhibitor of aromatase for the treatment of estrogen-dependent disease J Med Chem, 1991